logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Manufacturers
    3. Mayo Clinic

    Mayo Clinic drugs

    FiltersReset Filters
    4 results

    • ammonia n 13

      (ammonia n-13)
      Mayo Clinic
      Usage: Ammonia N 13 Injection USP is indicated for diagnostic PET imaging of the myocardium to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease, under resting or pharmacologic stress conditions.

    • choline c 11

      (Choline C-11)
      Mayo Clinic
      Usage: Choline C 11 Injection is indicated for PET imaging in patients with suspected prostate cancer recurrence, particularly when other imaging methods are inconclusive. It aids in identifying recurrence sites but does not replace histologic confirmation. Suspicions arise from elevated PSA levels following initial therapy.

    • fludeoxyglucose f 18

      (Fludeoxyglucose F-18)
      Mayo Clinic
      Usage: Fludeoxyglucose F 18 Injection USP is indicated for PET imaging to assess abnormal glucose metabolism in oncology for malignancy evaluation, in cardiology for identifying reversible left ventricular dysfunction in coronary artery disease, and in neurology to locate abnormal glucose metabolism related to epileptic seizures.

    • sodium fluoride f 18

      (sodium fluoride F 18)
      Mayo Clinic
      Usage: Sodium Fluoride F 18 Injection USP is indicated for diagnostic PET imaging of bone to identify areas of altered osteogenic activity.